AOA 2023: Pooled analysis of Gobi and Mojave studies for NOV03 treatment of MGD
June 23rd 2023Ahmad M. Fahmy, OD, FAAO, Dipl ABO, gives highlights of his AOA 2023 poster that was a pooled analysis of the Gobi and Mojave studies relevant to perfluorohexyloctane (NOV03) for dry eye disease associated with Meibomian gland dysfunction.